Myocarditis and pericarditis following mRNA COVID-19 vaccination in younger patients: is there a shared thread?
1Division of Pediatrics and Neonatology, San G Moscati Hospital, Aversa, Italy.
Expert Review of Cardiovascular Therapy
|February 18, 2022
Abstract:
Rare cases of myocarditis and pericarditis after COVID-19 mRNA vaccination have been recently reported in male adolescents and young adults. Acute myocarditis and pericarditis following COVID-19 mRNA vaccination in male adolescents and young adults may be connected with age-related lower levels of T-bet and PD-1 in predisposed individulas with T-bet polymorphisms by the release od autoreactive CD8+CTL. Upregulatiomn of T-Bet and PD-1 by estrogen might explai the higher incidence of men developing myocarditis or pericarditis in comparison to women.
Insights
Rare cases of myocarditis and pericarditis post-COVID-19 mRNA vaccination in young males may link to lower T-bet and PD-1 levels. Estrogen
Area of Science:
- Immunology
- Cardiology
- Vaccinology
Background:
- Recent reports indicate rare instances of myocarditis and pericarditis in male adolescents and young adults following COVID-19 mRNA vaccination.
- These cardiac conditions appear more frequently in males within this demographic.
Discussion:
- The study explores a potential link between age-related decreases in T-bet and PD-1 levels and the incidence of myocarditis/pericarditis.
- Predisposition may involve T-bet polymorphisms, leading to the release of autoreactive CD8+ cytotoxic T lymphocytes (CTL).
- Estrogen's role in upregulating T-Bet and PD-1 is hypothesized to explain the higher observed incidence in males compared to females.
Key Insights:
- A potential immunological mechanism involving T-bet, PD-1, and autoreactive T cells is proposed for post-vaccination myocarditis/pericarditis.
- Genetic factors (T-bet polymorphisms) and hormonal influences (estrogen) may contribute to sex-specific susceptibility.
- Understanding these factors could inform risk assessment and prevention strategies for vaccine-associated myocarditis.
Outlook:
- Further research is needed to validate the proposed mechanisms and identify specific T-bet polymorphisms.
- Investigating the precise role of estrogen in modulating immune responses post-vaccination is crucial.
- This work may pave the way for personalized risk stratification and improved vaccine safety monitoring.
Related Concept Videos
01:14Myocarditis III: Medical Management
27
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
27
01:21Myocarditis I: Introduction
52
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
52
01:27Myocarditis II: Clinical Features and Diagnostic Tests
38
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
38
01:22Pericarditis I: Introduction
32
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
32
01:22Myocarditis IV: Nursing Management
49
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
49
01:19Pericarditis II: Clinical Features and Diagnostic Tests
49
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
49